Altratech has developed and patented a fundamentally novel process to detect and quantify DNA, RNA, Antibody, and Antigen molecular targets. The process replaces the need for time consuming ‘biological amplification’ required for optical read-outs, with almost instant ‘electronic signal amplification’ and a digital read-out. This will enable a new generation of portable diagnostic products that have the simplicity of lateral flow tests and the performance of a laboratory PCR test.